Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Coda Octopus Group Inc is an aerospace & defense business based in the US. Coda Octopus Group shares (CODA) are listed on the NASDAQ and all prices are listed in US Dollars. Coda Octopus Group employs 95 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $5.15 |
|---|---|
| 52-week range | $4.75 - $9.90 |
| 50-day moving average | $5.37 |
| 200-day moving average | $7.00 |
| Wall St. target price | $8.00 |
| PE ratio | 16.1589 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.30 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.15 from 2022-07-01
| 1 week (2022-06-24) | 5.53% |
|---|---|
| 1 month (2022-06-02) | -2.28% |
| 3 months (2022-04-01) | -18.77% |
| 6 months (2021-12-31) | -35.63% |
| 1 year (2021-07-02) | -41.48% |
|---|---|
| 2 years (2020-07-02) | 0.78% |
| 3 years (2019-07-02) | 12.65 |
| 5 years (2017-06-30) | 22.62% |
Valuing Coda Octopus Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Coda Octopus Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Coda Octopus Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Coda Octopus Group shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Coda Octopus Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.7 million.
The EBITDA is a measure of a Coda Octopus Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $21.7 million |
|---|---|
| Operating margin TTM | 18.05% |
| Gross profit TTM | $14.8 million |
| Return on assets TTM | 5.6% |
| Return on equity TTM | 8.51% |
| Profit margin | 15.83% |
| Book value | $3.83 |
| Market capitalisation | $53.9 million |
TTM: trailing 12 months
We're not expecting Coda Octopus Group to pay a dividend over the next 12 months.
Coda Octopus Group's shares were split on a 1:14 basis on 10 January 2017. So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Coda Octopus Group shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for Coda Octopus Group shares which in turn could have impacted Coda Octopus Group's share price.
Over the last 12 months, Coda Octopus Group's shares have ranged in value from as little as $4.75 up to $9.9044. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Coda Octopus Group's is 1.4428. This would suggest that Coda Octopus Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Coda Octopus Group, Inc. , together with its subsidiaries, develops and sells underwater technologies and equipment for 3D imaging, mapping, defense, and survey applications in the Americas, Europe, Australia, Asia, the Middle East, and Africa. The company operates through two segments, Marine Engineering Business and Marine Technology Business. It sells technology solutions to the subsea and underwater markets. The company's solutions include geophysical systems, a geophysical data acquisition systems, processing, and analysis software that are used primarily by survey companies, offshore renewable companies, research institutions, and salvage companies; GNSS-aided navigation systems; Echoscope and Echoscope PIPE used for real time monitoring of cable installations for offshore wind projects; and diver augmented vision display system. It offers CodaOctopus GeoSurvey products, such as hardware and software solutions for field acquisition of sidescan sonar and sub-bottom profiler; and CodaOctopus DA4G productivity suite of software that automates the tasks of analyzing, annotating, and mosaicing complex data sets. It markets its products under the CodaOctopus brand name.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.